Identification of microRNA-93 as a functional dysregulated miRNA in triple-negative breast cancer

MicroRNAs (miRNAs) are widely recognized as key players in cancer progression and drug resistance, but less is known about the role of miRNAs in triple-negative (estrogen receptor, progesterone receptor, and HER-2/neu) breast cancer (TNBC). The aim of the present study was to examine the expression profile of miRNAs and to explore their possible roles in TNBC. Differentially expressed miRNAs were identified by miRNA microarray and verified by quantitative real-time polymerase chain reaction. The expression of miR-93 was assessed by in situ hybridization in 119 cases of breast cancer. Cell proliferation potential was examined by MTT assay. Cell migration and invasion abilities were evaluated by a wound healing assay and transwell invasion or migration assay. Seven upregulated and ten downregulated miRNAs in TNBC were identified. The miR-93 expression level in TNBC tissues was significantly higher than that in non-triple-negative breast cancer tissues. The potentials of proliferation, invasion, and metastasis in breast cancer MCF-7 cells were promoted by ectopic transfection of miR-93. Our study found several distinct differentially expressed miRNAs in TNBC, as compared to non-triple-negative breast cancer. Among them, miR-93 may be considered as a biomarker associated with the biological and clinical characteristics of human TNBC.

[1]  Yang Li,et al.  Role of the miR‐106b‐25 microRNA cluster in hepatocellular carcinoma , 2009, Cancer science.

[2]  Burton B. Yang,et al.  A 3′-Untranslated Region (3′UTR) Induces Organ Adhesion by Regulating miR-199a* Functions , 2009, PloS one.

[3]  T Takahashi,et al.  Apoptosis induction by antisense oligonucleotides against miR-17-5p and miR-20a in lung cancers overexpressing miR-17-92 , 2007, Oncogene.

[4]  J. Stenvang,et al.  The utility of LNA in microRNA-based cancer diagnostics and therapeutics. , 2008, Seminars in cancer biology.

[5]  Doron Betel,et al.  Genetic dissection of the miR-17~92 cluster of microRNAs in Myc-induced B-cell lymphomas. , 2009, Genes & development.

[6]  Yaou Zhang,et al.  MicroRNA MiR-17 retards tissue growth and represses fibronectin expression , 2009, Nature Cell Biology.

[7]  C. Perou,et al.  The Triple Negative Paradox: Primary Tumor Chemosensitivity of Breast Cancer Subtypes , 2007, Clinical Cancer Research.

[8]  Tae Hyun Kim,et al.  Breast cancer subtypes and survival in patients with brain metastases , 2008, Breast Cancer Research.

[9]  R. Askeland,et al.  MiR-93 enhances angiogenesis and metastasis by targeting LATS2 , 2012, Cell cycle.

[10]  Lin Zhang,et al.  KLF17 is a negative regulator of epithelial–mesenchymal transition and metastasis in breast cancer , 2009, Nature Cell Biology.

[11]  Ian O Ellis,et al.  Basal-like breast cancer: a critical review. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  Charles M. Perou,et al.  Triple-Negative Breast Cancer: Risk Factors to Potential Targets , 2008, Clinical Cancer Research.

[13]  Dimitrios Iliopoulos,et al.  MicroRNA Gene Networks in Oncogenesis , 2009, Current genomics.

[14]  Yaou Zhang,et al.  MicroRNA miR-378 Regulates Nephronectin Expression Modulating Osteoblast Differentiation by Targeting GalNT-7 , 2009, PloS one.

[15]  M. Espié,et al.  Exquisite Sensitivity of TP53 Mutant and Basal Breast Cancers to a Dose-Dense Epirubicin−Cyclophosphamide Regimen , 2007, PLoS medicine.

[16]  John McAnally,et al.  The endothelial-specific microRNA miR-126 governs vascular integrity and angiogenesis. , 2008, Developmental cell.

[17]  Wayne Tam,et al.  MicroRNAs in tumorigenesis: a primer. , 2007, The American journal of pathology.

[18]  Junxia Zhang,et al.  hsa-mir-181a and hsa-mir-181b function as tumor suppressors in human glioma cells , 2008, Brain Research.

[19]  Ling Fang,et al.  Expression of CD44 3′-untranslated region regulates endogenous microRNA functions in tumorigenesis and angiogenesis , 2010, Nucleic acids research.

[20]  Jie Yang,et al.  MicroRNA miR-93 promotes tumor growth and angiogenesis by targeting integrin-β8 , 2011, Oncogene.

[21]  F. Slack,et al.  The let-7 microRNA represses cell proliferation pathways in human cells. , 2007, Cancer research.

[22]  F. Slack,et al.  Oncomirs — microRNAs with a role in cancer , 2006, Nature Reviews Cancer.

[23]  Xiaolong Yang,et al.  LATS tumor suppressor: A new governor of cellular homeostasis , 2010, Cell cycle.

[24]  R. Knight,et al.  MiR-203 controls proliferation, migration and invasive potential of prostate cancer cell lines , 2011, Cell cycle.

[25]  Burton B. Yang,et al.  MicroRNA miR-199a-3p regulates cell proliferation and survival by targeting caveolin-2 , 2011, Journal of Cell Science.

[26]  Ru-Fang Yeh,et al.  miR-126 regulates angiogenic signaling and vascular integrity. , 2008, Developmental cell.

[27]  R. Weinberg,et al.  Tumour invasion and metastasis initiated by microRNA-10b in breast cancer , 2007, Nature.

[28]  Yaou Zhang,et al.  MicroRNA miR-328 Regulates Zonation Morphogenesis by Targeting CD44 Expression , 2008, PloS one.

[29]  W. Cho.  OncomiRs: the discovery and progress of microRNAs in cancers , 2007, Molecular Cancer.

[30]  D. Bartel.  MicroRNAs Genomics, Biogenesis, Mechanism, and Function , 2004, Cell.

[31]  D. Birnbaum,et al.  MicroRNA93 Regulates Proliferation and Differentiation of Normal and Malignant Breast Stem Cells , 2012, PLoS genetics.

[32]  N. Seki,et al.  microRNA-1/133a and microRNA-206/133b clusters: Dysregulation and functional roles in human cancers , 2012, Oncotarget.

[33]  Lin Zhang,et al.  The microRNAs miR-373 and miR-520c promote tumour invasion and metastasis , 2008, Nature Cell Biology.